Product Description: Ozanezumab (GSK1223249) is an anti-Nogo-A (neurite outgrowth inhibitor A) monoclonal antibody. Ozanezumab can be used in amyotrophic lateral sclerosis (ALS) and multiple sclerosis research[1].
Applications: Neuroscience-Neurodegeneration
Formula: N/A
References: [1]Meininger V, et al. Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2017 Mar;16(3):208-216.
CAS Number: 1310680-64-8
Molecular Weight: N/A
Research Area: Neurological Disease
Solubility: 10 mM in DMSO
Target: Others